Back | Next |
home / stock / agle / agle message board
Subject | By | Source | When |
---|---|---|---|
AGLE: And you are WELCOME, Boss!! And indeed, | Invest-in-America | investorshub | 06/22/2023 5:01:20 PM |
thank you. i'm just starting to do some | 1jas | investorshub | 06/22/2023 4:57:42 PM |
Nice to meet you. Your question is difficult | subslover | investorshub | 06/22/2023 4:47:36 PM |
Lol feeling .47/.42 bounce into close | Triple nickle | investorshub | 06/22/2023 4:41:09 PM |
21 cents to go to fair value | magacrew2020 | investorshub | 06/22/2023 4:36:49 PM |
new here. of course this stock just caught | 1jas | investorshub | 06/22/2023 4:14:24 PM |
Thanks, bro. Well these P&D's are all we | subslover | investorshub | 06/22/2023 4:03:15 PM |
AGLE: CONGRATS to ya, Boss!! (What a FREAKISH stock!!) | Invest-in-America | investorshub | 06/22/2023 3:37:43 PM |
I had a GTC order @ $1.00 that | subslover | investorshub | 06/22/2023 3:26:25 PM |
AGLE a good buy under .11, huge | WARHAMMER | investorshub | 06/22/2023 3:15:21 PM |
AGLE: Last chance to score here is RIGHT | Invest-in-America | investorshub | 06/22/2023 2:52:19 PM |
AGLE: Hey, Bro, I got NONE of this | Invest-in-America | investorshub | 06/22/2023 2:41:57 PM |
AGLE: Well, how MUCH did ya SCORE here, | Invest-in-America | investorshub | 06/22/2023 2:34:04 PM |
What price u enter? Nice | JusDePomme | investorshub | 06/22/2023 2:33:24 PM |
got bids in for .40 | Golden Cross | investorshub | 06/22/2023 2:32:16 PM |
what the hell is the real value of | Golden Cross | investorshub | 06/22/2023 2:31:46 PM |
Back to ninety cents | Triple nickle | investorshub | 06/22/2023 2:02:19 PM |
Looks like they had it spot on | Triple nickle | investorshub | 06/22/2023 1:45:34 PM |
Round two | Triple nickle | investorshub | 06/22/2023 1:41:08 PM |
AGLE: Monster THANKS for the heads-up, King Subs!!!! WOW!!! | Invest-in-America | investorshub | 06/22/2023 1:31:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Aeglea BioTherapeutics Inc. Company Name:
AGLE Stock Symbol:
NASDAQ Market:
Aeglea BioTherapeutics Inc. Website:
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD PR Newswire Company will begin trading on Nasdaq under trading sy...
2023-11-20 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Continued progress across the Company's potentially best-in-class inflammatory bowel disease (IBD) portfolio SPY001, a half-life extended anti-α4β...